Apoptosis and epithelial-to-mesenchymal transition (EMT) have been implicated in a variety of biological processes, such as embryonic development, fibrosis and tumor progression. Transforming growth factor-b (TGFb) can induce simultaneously both EMT and apoptotic response of epithelial cells. However, the underlying mechanism of these biological events remains not well understood. In the present study, we show that TGF-b1 induces apoptosis and EMT in AML-12 cells in a cell cycle-related manner, in which apoptosis and EMT took place at G2/M and G1/S phases, respectively. TGF-b1-induced apoptosis was correlated with different extent of caspase activation at different cell cycle phases. Interestingly, increased phosphorylation of protein kinase D (PKD) can be observed in G1/S phase in response to TGFb1, and inhibition of PKD by inhibitor or by small interference RNA blocked EMT but not apoptosis. Our data suggest a previously unrecognized role of cell cycle state in the regulation of TGF-b-induced EMT and apoptosis, and demonstrate that PKD is involved in the TGF-b1-induced EMT.
Introduction
Apoptosis is a major form of cell death important for the maintenance of body homeostasis and appropriate execution of developmental programs (Meier et al., 2000; Twomey and McCarthy, 2005) . It is now clear that caspase family of cysteine proteinases play pivotal roles in both the initiation and progression of cell apoptosis, and transforming growth factor-b (TGF-b)-induced apoptosis has been considered to be largely dependent on caspase activation (Schuster and Krieglstein, 2002) . Epithelial-to-mesenchymal transition (EMT) describes a morphological switch of cells from the epithelial polarized phenotype to the mesenchymal fibroblastoid phenotype. As a distinct biological phenomenon, EMT has been recognized to play pivotal roles in diverse physiological and pathological events, ranging from embryonic development to tumor metastasis (Gru¨nert et al., 2003; Kalluri and Neilson, 2003; Thiery, 2003; Prindull and Zipori, 2004; Huber et al., 2005) .
During recent years, EMT has also been emerging as a focus of intensive studies in cancer research, and increasing data indicate that EMT functions as a central step in the invasion and metastasis of some tumor cells. EMT has been shown to be a complicated multistep process instead of simply a morphological transition. Besides the cytoskeleton rearrangement and the subsequent morphological changes, EMT is often characterized by the dissolution or attenuation of epithelial adhesion and other polarized structures, for example, tight junctions, and by accordingly the acquisition of migratory and invasive properties of the cells undergoing EMT. Along with these changes, EMT can be associated with transcriptional or expressional alterations of some epithelial and mesenchymal genes. For example, the expression levels of ZO-1 and E-cadherin, which are, respectively, the components of epithelial tight junction and adhesion, can be downregulated; conversely, the expression of vimentin, which is a mesenchymal-specific intermediate filament protein, can be upregulated during the EMT. It has been reported that signaling molecules, including Smad (Piek et al., 1999) , phosphatidylinositol 3'-kinase (Bakin et al., 2000) , Rho-A (Bhowmick et al., 2001) , p38 (Bakin et al., 2002) , Erk (Xie et al., 2004) , Disabled-2 (Prunier and Howe, 2005) and Par-6 (Ozdamar et al., 2005) , were involved in the regulation of TGF-b-induced EMT. Although the TGF-b-induced EMT has received much attention in recent years, the underlying signaling mechanism still remains not well understood.
TGF-b is a pluripotent factor that can elicit multiple cellular responses, even in the same cell type. In epithelial cells, TGF-b is able to induce both cell apoptosis and EMT. More and more cellular signaling molecules other than Smad have been found to be associated with the signaling processes mediated by TGF-b family members. For example, protein kinase D (PKD) has been shown to be involved in the bone morphogenetic protein-2-induced activation of c-Jun NH 2 -terminal kinase and p38 MAP kinases and osteoblastic cell differentiation (Lemonnier et al., 2004) , and p38 MAP kinase has been shown to play a critical role in TGF-b1-induced apoptosis in AML-12 murine hepatocytes (Liao et al., 2001) .
The roles of TGF-b in the regulation of proliferation, apoptosis and EMT in epithelial cells have been documented; nevertheless, the mechanism that underlies the TGF-b-mediated concurrent apoptosis and EMT remains poorly understood. TGF-b-induced growth arrest is often accompanied with other cellular responses, for example, the aforementioned apoptosis and EMT. This fact implies a possibility of the correlation between the TGF-b-induced growth arrest and other cellular responses. As TGF-b-induced growth arrest is an event related with the changes of cell cycles, it implies that different cell cycle states may be linked with the distinct responsibility of cells to TGF-b treatment.
There are two interesting observed facts: first, after stimulation of AML-12 cells with TGF-b1 for certain times, pronounced apoptosis was induced, but it took much longer time for most cells to undergo apoptosis. The second fact is that besides apoptosis, TGF-b1 also induces simultaneously the EMT. In other words, the cells could respond differentially to TGF-b1 stimulation under the same experimental conditions. The mechanism underlying this mystical character of cellular responses to TGF-b1 remains ill-defined. Why only a portion but not most of cells die within a specific time length after treated with TGF-b1? What is the cause that leads to distinct cellular fates in response to TGF-b1 treatment? It seems that the answer to the second question may also be the answer to the first question because these two independent phenomena of cellular response to TGF-b1 are closely related concurrent events. The studies may contribute to a better understanding of the regulatory mechanism of TGF-b on cellular fates, which could also be potentially of importance in related areas of medicine.
Results

TGF-b1 induces cell growth arrest, apoptosis and EMT
We have previously shown that treatment of AML-12 hepatocytes with TGF-b1 induced caspase-dependent apoptosis . In the further studies, we observed that TGF-b1 also concomitantly induces EMT in AML-12 cells (Figure 1a) , which was associated with decrease in the expression levels of ZO-1 and E-cadherin ( Figure 1b ). It has been well known that TGF-b has potent inhibitory effect on the proliferation of most epithelial cells, so we examined the effect of TGF-b1 on the proliferation of AML-12 cells. As it was shown, TGF-b1 can induce cell growth arrest in both dose-and As TGF-b1-induced apoptosis and EMT are also concomitant with TGF-b1-mediated growth arrest, it is possible that TGF-b1-induced growth arrest is related with TGFb1-induced EMT.
TGF-b1-induced apoptosis and EMT are related with the cell cycle state To investigate the mechanism of distinct cellular responses (apoptosis and EMT), we examined the contribution of cell cycle state. Firstly, we synchronized the cells at G1/S or G2/M phase and examined TGF-b1 induced EMT and apoptosis. As shown in Figure 2a , TGF-b1 induced EMT in cells non-synchronized or those synchronized at G1/S phase, whereas it did not induce EMT in cells synchronized at G2/M phase. Consistent with above results, the immunofluorescent staining of ZO-1 and b-actin showed that TGF-b1 induces the loss of tight junction and rearrangement of cytoskeleton in non-synchonized cells and cells at G1/ S phase, but not in cells at G2/M phase ( Figure 2b ). Same results were obtained by examining the expression levels of ZO-1 and E-cadherin ( Figure 2c ). Interestingly, synchronization of cells at G1/S phase markedly reduced apoptotic response. In sharp contrast, a dramatic increase of apoptosis was induced in cells synchronized at G2/M phase as measured by fluorescence-activated cell sorter (FACS) ( Figure 3a ) and DNA fragmentation (Figure 3b ) assays. To confirm these phenomena, we examined the TGF-b1-induced caspase activity in cells synchronized at different cycle phases. As compared with the caspase activity in non-synchronized cells, TGF-b1-induced caspase activity is much lower in cells synchronized at G1/S phase, but significantly higher in cells synchronized at G2/M phase (Figure 3c ), suggesting a causative linkage between cell cycle-related caspase activation and the TGF-b1-induced apoptosis. These results indicate that TGF-b1-induced apoptosis and EMT are related with the cell cycle state; the apoptosis was induced mostly in cells at G2/M phase, whereas EMT was only induced in cells at G1/S phase.
PKD plays an important role in TGF-b1-induced EMT To investigate the potential molecular mechanism through which TGF-b1 induced these two events, we examined the role of PKD in TGF-b1 induced these events. Treatment of cells with TGF-b1 induced both time- (Figure 4a ) and dose-dependent (Figure 4b ) increase in the level of phosphorylated PKD, implying that PKD is a component of TGF-b1 signaling. Interestingly, the TGF-b1-induced increase of PKD phosphorylation can only be detected at G1/S but not G2/M phase (Figure 4c ). Through examining the changes of cell morphology (Figure 5a ) and the intracellular distribution of ZO-1 and b-actin (Figure 5b ), we also found that PKD/PKC inhibitor Go¨6976 can block the TGF-b1-induced EMT, whereas the PKC inhibitor Go¨6983, which does not inhibit PKD, showed no obvious effect on TGF-b1-induced EMT.
Examination of the expression levels of ZO-1 and E-cadherin (Figure 5c ) produced the same results.
To confirm the role of PKD in TGF-b1-induced EMT, we transfected the cells with small interference RNA specific for PKD, which reduced the expression level of PKD (Figure 6a) , then investigated the response of these cells to TGF-b1 treatment. The results showed that the downregulation of PKD by RNA interference suppressed TGF-b1-induced morphological change ( Figure 6b ) and decreased ZO-1 and E-cadherin expression (Figure 6c) . Consistently, TGF-b1-induced changes of tight junction and cytoskeleton were also blocked in the PKD-downregulated cells (Figure 6d ). These results suggested that PKD played a role in the induction of EMT. We also investigated whether PKD also involved in TGF-b1-induced apoptosis. As shown in Figure 7 , Go¨6976 and Go¨6983 had no effect on TGF-b1-induced apoptosis as measured by FACS (Figure 7a ) and DNA fragmentation (Figure 7b ) assays, and the same results were obtained in cells transfected with small interference RNA for PKD (Figure 7c ). These data indicate that PKD is involved in the TGF-b1-mediated EMT, but not apoptosis.
Discussion
We observed that TGF-b1 was able to induce not only apoptosis but also the EMT in several epithelial cell lines. We attempt to understand how can a factor induce these concurrent but distinct events in the same type of cells or why did the same type of cells respond differentially to the same factor under the same experimental conditions. The most likely factor that determines the different responses and thus the different fates of cells to the same stimuli could be the differences of cells themselves. As it has been well known that the cell cycle progression is associated with alterations in cellular components and corresponding signaling events, there might be a relationship between the cell cycle progression and TGF-b1-induced apoptosis and EMT. Although increasing evidence showed that the cell cycle state is an important factor for cellular responses to extracellular stimuli, very little attention has been given to the two distinct cellular responses induced by the same stimuli for the same cells, for example, in the case of TGF-b1-induced concomitant apoptosis and EMT.
The observation that TGF-b1-induced caspase activity in cells synchronized at G2/M phase was significantly higher than cells at G1/S phase provided an explanation on how TGF-b1 induced very strong apoptosis in these cells. It has been widely known that growth arrest is required for cells to undergoing differentiation. As TGF-b1-induced EMT occurred in G1/S phase, TGFb1-induced G1/S phase growth arrest may provide cells a precondition for undergoing EMT. TGF-b1-induced EMT of cells at G1/S phase explained how cells survived the TGF-b1 treatment under the same condition. It is obvious that in regular cell cultures without synchronization, cells are highly heterogeneous in terms of cell Cell cycle-related EMT and apoptosis Y Yang et al cycle phases and will therefore respond differentially to TGF-b1, leading to different cell fates. These data not only explained why not all cells undergo apoptosis within a defined relatively short period of TGF-b1 treatment but also provided a new insight into the mechanism through which the same signal molecule (TGF-b1) induces concomitantly different cellular fates in the same cell type, which could be important in the Figure 2 TGF-b1-induced EMT was dependent on the cell cycle state. Non-synchronized cells and cells synchronized at G1/S or G2/ M phase were treated with TGF-b1 (5 ng/ml) for 36 h. EMT was examined by morphological change (a), and by immunofluorescent staining (b) of ZO-1 (red), b-actin (green) and nuclei (blue, DAPI staining). (c) Cells were treated with TGF-b1 as in (a) and (b). ZO-1 and E-cadherin expression levels were detected by Western blotting.
Cell cycle-related EMT and apoptosis Y Yang et al
understanding of the multifunctional effects of TGF-b in some physiological and pathological processes. It has been reported that the EMT conferred the cells resistance to TGF-b1-induced apoptosis in fetal rat hepatocytes (Valde´s et al., 2002) . This phenomenon may not be restricted to the TGF-b1-induced apoptosis and EMT, as Snail-induced EMT has also been reportedly associated with the blockage of cell cycle and the resistance to different proapoptotic stimuli-induced apoptosis (Vega et al., 2004) .
PKD belongs to a newly identified family of diacylglycerol-stimulated serine/threonine protein kinases, which was previously designated as a subgroup of the PKC family (Van Lint et al., 2002; Bollag et al., 2004) . The biological functions of PKD have not been fully elucidated yet, and increasing data suggest that this family of protein kinases is involved in the regulation of diverse fundamental processes. Interestingly, PKD has also been implicated in the regulation of cell adhesion and migration (Kennett et al., 2004; Prigozhina and Waterman-Storer, 2004; Qiang et al., 2004; Woods et al., 2004) . Furthermore, PKD has been shown to be able to interact directly with cytoskeleton proteins cortactin and paxillin (Bowden et al., 1999) , which can be involved in the regulation of the morphology and the motility of cells. We found in this study that PKD is involved in TGF-b1-induced EMT but not apoptosis.
TGF-b1-induced apoptosis and EMT could be two mutually exclusive processes in a physiological context, because these two events have been shown to contribute (24 h). HU, hydroxyurea; NOC, nocodazole. (c) Non-synchronized cells and synchronized cells were treated with TGF-b1 (5 ng/ml) for 24 h. Caspase activity was examined as described in 'Materials and methods', and caspase activity in non-treated cells was set as 1. Cas-1 IV: capase-1 substrate IV; Cas-1 VII: capase-1 substrate VII; Cas-3 I: capase-3 substrate I; Cas-6: capase-6 substrate; and Cas-8: capase-8 substrate.
Cell cycle-related EMT and apoptosis Y Yang et al differentially to the effects of TGF-b on tumor progression and embryonic development. For example, TGF-b was suggested to have two 'faces' in its relationship with tumor formation and progression (Derynck et al., 2001; Thiery, 2002; Wakefield and Roberts, 2002) . Our data suggested that the different 'faces' of TGF-b can be seen simultaneously. It is highly possible that TGF-b in reality shows both or different faces in all stages of cancer development as well as in embryogenesis, as its sum total effects lie on cellular context and the specific state of cells. The sensitivity of tumor cells to TGF-b may be on the one hand determined by the genetic basis, such as gene mutation, TGF-b receptor deletion or other alterations, and on the other hand occasioned by the cell cycle state. Besides, in early embryogenesis, the differentiation, migration or apoptotic response to TGF-b may also be regulated, at least partly, by the cell cycle state. Thus, in addition to specific components of TGF-b signaling pathway, cell cycle phase could also be added as a factor in the consideration of the strategies of clinical therapy, including the cancer treatment.
Materials and methods
Materials
Cell culture reagents were purchased from Invitrogen (Carlsbad, CA, USA). [ 3 H-methyl]thymidine was purchased from NEN Life Science Products (Boston, MA, USA), AML-12 cells were from American Type Culture Collection (ATCC, Manassas, VA, USA) and caspase substrates, Go¨6976 and Go¨6983, were from Calbiochem (La Jolla, CA, USA). Rabbit polyclonal antibodies for ZO-1 and PKD, goat polyclonal antibodies for E-cadherin and b-actin, horseradish peroxidaseconjugated anti-rabbit and anti-goat secondary antibodies, bovine anti-rabbit (Texas Red), anti-mouse (fluorescein-isothiocyanate (FITC)) and anti-goat (FITC) secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), rabbit polyclonal antibody for p-PKD was from Cell Signaling (Beverly, MA, USA) and nitrocellulose membrane was purchased from Amersham Pharmacia Biotech (Buckinghamshire, UK). Super signal reagents were purchased from Pierce (Rockford, IL, USA). Other reagents were from Sigma (St Louis, MO, USA), unless otherwise indicated.
Cell culture AML-12 cells were grown in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium containing 10% fetal calf serum (GIBCO-BRL, Invitrogen Corp., Carlsbad, CA, USA) and supplied with insulin (5 mg/ml), transferrin (5 mg/ml), selenium (5 mg/ml), dexamethasone (40 ng/ml), 100 U/ml penicillin and 100 mg/ml streptomycin. The cells were incubated at 371C in a humidified atmosphere of 10% CO 2 until 70-80% confluence was reached.
Cell proliferation assay [
3 H]thymidine (0.2 mCi/ml) was added to label the cells during the last 4 h of incubation. Cells were then washed with ice-cold phosphate-buffered saline (PBS) and followed by incubation with 12% trichloroacetic acid on ice for 30 min. The acidinsoluble material was dissolved in lysis buffer (containing 1% sodium dodecyl sulfate (SDS) and 0.2 N NaOH) and moved into scintillation vials, mixed with 2.5 volumes of BCS. The DNA-associated 3 H-labeled radioactivity was determined by liquid scintillation spectrometry.
Examination of morphological change
The morphological changes of the cells were observed under the inverted phases-contrast microscope (Olympus). The photographs were taken at Â 400 magnitude using Kodak-200 films.
Preparation of cell lysates and immunoblotting
Cells were lysed in lysis buffer containing 50 mM N-2-hydroxyeethyl-piperazine-N-2-ethanesulfonic acid (HEPES) (pH 7.4), 5 mM ethylene-diaminetetraacetic acid (EDTA), 50 mM NaCl, 1% Triton X-100, 50 mM NaF, 10 mM Na 4-P 2 O 7 Á 10H 2 O, 5 mg/ml aprotinin, 5 mg/ml leupeptin, 1 mM Na 3 VO 4 and 1 mM phenylmethylsulfonyl fluoride. Thirty micrograms of proteins were electrophoresed in SDS-polyacrylamide gel and transferred onto nitrocellulose membranes. The membranes were subsequently blocked with 5% skim milk and incubated with appropriate antibodies. Protein bands were visualized with super signal reagents.
Immunofluorescence staining and confocal microscopy Cells were grown on glass slides and treated as indicated. The slides were quickly washed with PBS followed by fixing in 100% methanol at À201C for 10 min. The samples were subjected to probing with appropriate primary and secondary antibodies (Texas Red-conjugated anti-rabbit antibody, red fluorescence; FITC-conjugated anti-goat antibody, green fluorescence). The nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) (blue fluorescence). The fluorescence was visualized under confocal microscopy (Leica).
Cell cycle analysis and synchronization Cell cycle state was quantitatively determined by flow cytometry analysis as described previously (Zhao et al., . The percentage of cells with a sub-G1 DNA content was taken as a measure of the apoptotic rate of the cell population. To synchronize the cells to the G1/S boundary, cells were maintained in culture medium supplemented with 0.5 mM hydroxyurea for 24 h. G2/M synchronization was achieved by maintaining the cells in culture medium supplemented with 0.5 mg/ml nocodazole for 20 h. After being synchronized to G1/S or G2/M phase, cells were treated by TGF-b1 for another 24 h for apoptotic analysis or 36 h for EMT analysis in the presence of hydroxyurea or nocodazole.
Caspase activity assay Cells were collected and resuspended in ice-cold lysis buffer containing 50 mM HEPES (pH 7.4), 100 mM NaCl, 0.1% 3-[(3-cholamido propyl)-dimethylammonio]-2-hydroxy-1-propanesulfonic acid (CHAPS), 2 mM dithiothreitol (DTT), 0.1 mM EDTA for 15 min on ice and centrifuged at 12 000 Â g for 15 min at 41C. The supernatants (cytosolic extract) were collected as the samples for caspase activity detection. The samples were incubated with 500 mM caspase substrates in 100 ml caspase activity assay buffer (50 mM HEPES (pH 7.4), 100 mM NaCl, 0.1% CHAPS, 10 mM DTT, 0.1 mM EDTA Cell cycle-related EMT and apoptosis Y Yang et al and 10% glycerol) for 4 h at 371C. Optical density was measured at 405 nm.
RNA interference
We synthesized the DNA sequences corresponding to the small interference RNA sequence for mouse PKD as reported (Storz and Toker, 2003) with minor modification as follows: sense: 5 0 -GATCC ATGCTGTGGGGGCTGGTGCTTCAAGAGA GCACCAGCCCCCACAGCATTTTTTTGGAAA-3 0 , antisense: 5 0 -AGCTTTTCCAAAAAAATGCTGTGGGGGCTG GTGCTCTCTTGAAGCACCAGCCCCCACAGCATG-3 0 . The DNA sequences were then cloned into pSilencer-3.1 and RNA interference experiment was performed using a kit (Ambion, Texas, USA) under the manufacturer's instruction.
DNA fragmentation assay DNA fragmentation of apoptotic cells was performed as described previously .
Statistical analysis
Results are presented as means7s.d.'sfor the number of experiments indicated. Statistical analysis was made by Student's t-test. Differences were considered significant at a level of *Po0.05. Significant at **Po0.01.
Abbreviations
EMT, epithelial-to-mesenchymal transition; TGF-b, transforming growth factor-b; PKD, protein kinase D.
